New hope for tough bladder cancers: first human trial begins
Disease control
Recruiting now
This is an early-stage study testing a new drug called RAG-01 for people with a specific type of bladder cancer that has returned after standard BCG treatment. The main goals are to check if the drug is safe, see how the body processes it, and find the best dose for future testin…
Phase: PHASE1 • Sponsor: Ractigen Therapeutics. • Aim: Disease control
Last updated Mar 02, 2026 15:22 UTC